Sialidase NEU3 Contributes to the Invasiveness of Bladder Cancer

Sialidase NEU3 Contributes to the Invasiveness of Bladder Cancer

Bladder cancer is the 10th most commonly diagnosed cancer worldwide. The current standard treatment for advanced bladder cancer is neoadjuvant cisplatin (NAC)-based chemotherapy followed by cystectomy. However, the response rate to chemotherapy is only 50%, owing to cisplatin resistance, and there i...

Full description

Bibliographic Details
Main Authors: Takeo Tatsuta, Jun Ito, Koji Yamamoto, Shigeki Sugawara, Masahiro Hosono, Makoto Sato, Taeko Miyagi
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Biomedicines
Subjects:
sialidase
invasion
bladder cancer
Online Access:https://www.mdpi.com/2227-9059/12/1/192

Internet

https://www.mdpi.com/2227-9059/12/1/192

Similar Items